Drug Type Chemical drugs |
Synonyms CBB 3001, CBB3001 |
Target |
Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H27NO5 |
InChIKeyVVFYDJJSFHIMKO-LSDHHAIUSA-N |
CAS Registry1639358-50-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Embryonal Carcinoma | Preclinical | US | 01 May 2018 | |
Teratocarcinoma | Preclinical | US | 01 May 2018 |